Home / Themes / Neurotech '26: Noninvasive Brain Stimulation

Neurotech '26: Noninvasive Brain Stimulation (open on stockthemes)

Last updated

Theme thesis · 2/5 sections · Tickers 0 with notes · 9 pending

Loading chart…
Loading…

Bull / Bear Details has the investment thesis and bull/bear points. Overview is monitoring guidance (hiring, forums, second-order trends, search keywords, Google Trends, datasets).

Bull / Bear Details

Noninvasive brain-stimulation companies develop external magnetic and electrical technologies that modulate cortical activity without surgically implanted elect

Thesis

Noninvasive brain-stimulation companies develop external magnetic and electrical technologies that modulate cortical activity without surgically implanted electrodes. The theme captures transcranial magnetic stimulation, transcranial direct current stimulation, navigated targeting systems and emerging feedback-guided stimulation platforms. Demand is driven by patients with treatment-resistant psychiatric disorders, neurological rehabilitation needs, expanding insurance coverage and the development of more personalized stimulation protocols. Equipment installations, recurring treatment sessions, specialized coils and software create differentiated revenue opportunities.

Bull case

  • Expanded clinical evidence and reimbursement for transcranial magnetic stimulation in depression, OCD and additional psychiatric indications increase treatment accessibility and utilization across outpatient clinics and hospitals.

  • Accelerated stimulation protocols, individualized brain targeting and EEG- or imaging-guided treatment improve procedural efficiency and therapeutic precision, potentially increasing patient throughput and expanding adoption beyond specialized academic centers.

  • Transcranial electrical stimulation and multimodal neurorehabilitation platforms create additional treatment opportunities following stroke and neurological injury, extending noninvasive brain stimulation beyond its established psychiatric applications.

Bear case

  • Inconsistent clinical outcomes, limited durability of treatment benefits and uncertain evidence for emerging indications restrict payer coverage and physician adoption, particularly outside established depression treatment protocols.

  • High initial equipment costs, clinic staffing requirements, repeated treatment visits and reimbursement restrictions constrain patient access and reduce the economics of specialized stimulation centers.

  • Competition among magnetic stimulation manufacturers, lower-cost equipment suppliers, alternative psychiatric medications and emerging home-based treatments pressures system pricing, treatment utilization and the commercial differentiation of stimulation technologies.

Overview

Hiring Trend Watchpoints

High-performing operators are expanding reimbursement navigators and market access liaisons to convert broadened payer policies (such as expanded OCD coverage and adolescent MDD) into active clinic authorizations. System manufacturers integrating into treatment delivery (notably Neuronetics following its Greenbrook clinic consolidation) show elevated hiring for certified TMS technicians, patient coordinators, and clinic operations managers. On the R&D side, headcount growth is concentrated in electrical-field modeling, MRI/EEG co-registration software, and automated robotic positioning engineers. Early warning signs of theme deterioration include layoffs among clinical site technicians, attrition in dedicated payer billing support teams, or freezes in field sales specialists responsible for converting psychiatric private practices to capital lease arrangements.

Forum Watchlist

  • reddit — r/TMSHigh

    Patient real-world outcomes, tolerance of accelerated high-frequency protocols (SWIFT/SAINT), out-of-pocket costs, and insurer prior-authorization friction

  • reddit — r/PsychiatryHigh

    Clinician sentiment regarding TMS efficacy vs. esketamine/Spravato, patient referral bottlenecks, clinic staffing requirements, and procedural billing economics

  • niche_community — Clinical TMS Society (CTMSS) Member ForumsHigh

    Physician discussions on clinical guidelines, CPT code reimbursement shifts, technician training standards, and navigated E-field mapping adoption

  • reddit — r/tDCSMedium

    Community reports on noninvasive direct current stimulation safety, device montage accuracy, stroke recovery protocols, and home-use stimulation hardware

  • patient_community — HealthUnlocked Migraine & Headache CommunityMedium

    Patient uptake, prescription access through VA or commercial plans, and adherence to handheld noninvasive vagus nerve stimulators like gammaCore

Industry Publications

  • Brain Stimulation Journal (brainstimjrnl.com) — The leading peer-reviewed journal dedicated to clinical trials, stimulation physics, navigated targeting, and protocol evolution across TMS, tDCS, and vagus nerve neuromodulation.
  • Psychiatric Times (psychiatrictimes.com) — Essential clinical psychiatry coverage tracking real-world interventional psychiatry adoption, provider economics, guideline recommendations, and comparative data against pharmacotherapy.
  • MedTech Dive (medtechdive.com) — Premier industry coverage of FDA clearances, corporate restructurings, M&A integrations (such as device-clinic mergers), and reimbursement landscape developments.
  • Neurotech Reports (neurotechreports.com) — Dedicated business and market intelligence publication covering commercial neuromodulation platforms, patent litigation, and emerging venture/public neurotech investments.
  • Neuromodulation Journal (neuromodulationjournal.org) — Official journal of the International Neuromodulation Society, publishing clinical safety guidelines, health-economic assessments, and multi-center efficacy registries.

Second Order Trends

First, the industry is transitioning from standard 6-week daily treatment schedules toward accelerated theta-burst and multi-session protocols (such as BrainsWay's SWIFT and Stanford SAINT variants), which compress treatment into a matter of days and drastically improve patient retention. Second, hardware makers are vertically integrating with brick-and-mortar clinics (highlighted by Neuronetics absorbing Greenbrook TMS), pivoting business models from pure equipment manufacturing to hybrid device-service recurring treatment revenue. Third, precision neuronavigation using individual structural and functional MRI targeting (advancing beyond traditional scalp measurements) is transitioning from academic research centers into commercial outpatient systems. Fourth, Asian manufacturers are expanding noninvasive neuromodulation beyond psychiatry into multimodal neurological stroke rehabilitation, combining TMS and tDCS with electromyography and robotic motion systems. Finally, noninvasive peripheral neuromodulation (e.g., handheld vagus nerve stimulation) is gaining momentum in headache and wellness disorders through self-administered, HSA-eligible direct consumer access models.

Search Keywords Brand Product

  • NeuroStar
  • Deep TMS
  • H-Coil
  • gammaCore
  • gammaCore Sapphire
  • SWIFT protocol
  • NBS System 6
  • tesLAB
  • innk
  • ALTMS
  • Blossom TMS
  • Xneuro
  • Truvaga
  • TAC-STIM
  • noninvasive brain stimulation
  • transcranial magnetic stimulation
  • TMS therapy
  • deep TMS
  • accelerated TMS
  • transcranial direct current stimulation
  • vagus nerve stimulation
  • interventional psychiatry
  • neuromodulation therapy

Search Keywords Policy Regulatory

  • FDA 510(k) clearance
  • CPT 90867
  • CPT 90868
  • CPT 90869
  • Medicare Coverage Determination TMS
  • prior authorization major depressive disorder
  • OCD insurance policy coverage
  • HSA FSA eligible neuromodulation

Search Keywords Event Phrases

  • Clinical TMS Society Annual Meeting
  • American Psychiatric Association Annual Meeting
  • North American Neuromodulation Society Annual Meeting
  • International Conference on Non-Invasive Brain Stimulation
  • FDA Neurological Devices Panel

Google Trend Product Category Intent

• TMS therapy near me • deep TMS therapy • vagus nerve stimulator • TMS machine cost • tDCS device • gammaCore prescription

Google Trend Consumer Intent

• TMS therapy for depression • TMS therapy for OCD • does insurance cover TMS • TMS therapy side effects • migraine vagus nerve stimulation • TMS success rate

Google Trend Macro Policy Terms

• Medicare TMS coverage • TMS insurance approval • FDA approved TMS devices • CPT code 90868 reimbursement

Economic Data Watch

1. FRED — Gross Domestic Product

Matchedfred · access=api · map_only

Metric/field GDP

Cadence monthly

Why it matters Overall economic health influences healthcare spending, investment in new technologies, and patient affordability for treatments.

Signal to watch Increasing GDP suggests a stronger economy, potentially leading to higher healthcare spending and adoption of new treatments.

Confidence: high

2. FRED — Unemployment Rate

Matchedfred · access=api · map_only

Metric/field UNRATE

Cadence monthly

Why it matters Lower unemployment often correlates with higher rates of employer-sponsored health insurance and greater disposable income for healthcare expenses, which can improve access to noninvasive brain stimulation therapies.

Signal to watch Decreasing unemployment rate indicates improved economic conditions, potentially boosting insurance coverage and patient access.

Confidence: high

3. FRED — Consumer Price Index for All Urban Consumers: Medical Care Services

Matchedfred · access=api · map_only

Metric/field CPIMEDSL

Cadence monthly

Why it matters Tracks inflation specifically within medical care services, impacting the cost of delivering treatments and influencing reimbursement rates for noninvasive brain stimulation procedures.

Signal to watch Stable or declining growth in medical care CPI could indicate more favorable cost environments for providers and payers.

Confidence: high

4. FRED — Federal Funds Effective Rate

Matchedfred · access=api · map_only

Metric/field DFF

Cadence monthly

Why it matters Influences borrowing costs for healthcare providers (e.g., clinics purchasing TMS systems) and for companies funding R&D and expansion of noninvasive brain stimulation technologies.

Signal to watch Stable or decreasing interest rates can make capital more accessible for investment in equipment and expansion.

Confidence: high

5. FRED — Personal Consumption Expenditures: Health Care

Matchedfred · access=api · map_only

Metric/field PCEDG

Cadence monthly

Why it matters A direct measure of consumer spending on healthcare, reflecting patient willingness and ability to pay for services, including noninvasive brain stimulation therapies.

Signal to watch Increasing PCE on healthcare suggests growing demand and affordability for medical services.

Confidence: high

Free Alt Data Watch

1. ClinicalTrials.gov — Clinical Trial Registry

Not in registry

Metric/field Number of new studies, study status changes, enrollment numbers

Cadence daily

Why it matters New trials, advancements in study phases, or increased enrollment indicate ongoing research, potential for new indications, and growing clinical interest in noninvasive brain stimulation technologies.

Signal to watch Increasing number of new trials or trials advancing to later phases (e.g., Phase 3) suggests potential for future market expansion and regulatory approvals.

Confidence: high

2. FDA — 510(k) Premarket Notification Database / PMA Database

Not in registry

Metric/field Device clearances/approvals for product codes OBF, OBN, OBP, GBN, GBS, GBT, GCA, GCB, GCE, GCF, GCG, GCH, GCI, GCJ, GCK, GCL, GCM, GCN, GCO, GCP, GCQ, GCR, GCS, GCT, GCU, GCV, GCW, GCX, GCY, GCZ, HBS, HBT, HBU, HBV, HBW, HBX, HBY, HBZ, IBN, IBO, IBP, IBQ, IBR, IBS, IBT, IBU, IBV, IBW, IBX, IBY, IBZ, JBN, JBO, JBP, JBQ, JBR, JBS, JBT, JBU, JBV, JBW, JBX, JBY, JBZ, KBN, KBO, KBP, KBQ, KBR, KBS, KBT, KBU, KBV, KBW, KBX, KBY, KBZ, LBN, LBO, LBP, LBQ, LBR, LBS, LBT, LBU, LBV, LBW, LBX, LBY, LBZ, MBN, MBO, MBP, MBQ, MBR, MBS, MBT, MBU, MBV, MBW, MBX, MBY, MBZ, NBN, NBO, NBP, NBQ, NBR, NBS, NBT, NBU, NBV, NBW, NBX, NBY, NBZ, OBN, OBO, OBP, OBQ, OBR, OBS, OBT, OBU, OBV, OBW, OBX, OBY, OBZ, PBN, PBO, PBP, PBQ, PBR, PBS, PBT, PBU, PBV, PBW, PBX, PBY, PBZ, QBN, QBO, QBP, KBQ, QBR, QBS, QBT, QBU, QBV, QBW, QBX, QBY, QBZ, RBN, RBO, RBP, RBQ, RBR, RBS, RBT, RBU, RBV, RBW, RBX, RBY, RBZ, SBN, SBO, SBP, SBQ, SBR, SBS, SBT, SBU, SBV, SBW, SBX, SBY, SBZ, TBN, TBO, TBP, TBQ, TBR, TBS, TBT, TBU, TBV, TBW, TBX, TBY, TBZ, UBN, UBO, UBP, UBQ, UBR, UBS, UBT, UBU, UBV, UBW, UBX, UBY, UBZ, VBN, VBO, VBP, VBQ, VBR, VBS, VBT, VBU, VBV, VBW, VBX, VBY, VBZ, WBN, WBO, WBP, WBQ, WBR, WBS, WBT, WBU, WBV, WBW, WBX, WBY, WBZ, XBN, XBO, XBP, XBQ, XBR, XBS, XBT, XBU, XBV, XBW, XBX, XBY, XBZ, YBN, YBO, YBP, YBQ, YBR, YBS, YBT, YBU, YBV, YBW, YBX, YBY, YBZ, ZBN, ZBO, ZBP, ZBQ, ZBR, ZBS, ZBT, ZBU, ZBV, ZBW, ZBX, ZBY, ZBZ, ABN, ABO, ABP, ABQ, ABR, ABS, ABT, ABU, ABV, ABW, ABX, ABY, ABZ, BBN, BBO, BBP, BBQ, BBR, BBS, BBT, BBU, BBV, BBW, BBX, BBY, BBZ, CBN, CBO, CBP, CBQ, CBR, CBS, CBT, CBU, CBV, CBW, CBX, CBY, CBZ, DBN, DBO, DBP, DBQ, DBR, DBS, DBT, DBU, DBV, DBW, DBX, DBY, DBZ, EBN, EBO, EBP, EBQ, EBR, EBS, EBT, EBU, EBV, EBW, EBX, EBY, EBZ, FBN, FBO, FBP, FBQ, FBR, FBS, FBT, FBU, FBV, FBW, FBX, FBY, FBZ, GBN, GBO, GBP, GBQ, GBR, GBS, GBT, GBU, GBV, GBW, GBX, GBY, GBZ, HBN, HBO, HBP, HBQ, HBR, HBS, HBT, HBU, HBV, HBW, HBX, HBY, HBZ, IBN, IBO, IBP, IBQ, IBR, IBS, IBT, IBU, IBV, IBW, IBX, IBY, IBZ, JBN, JBO, JBP, JBQ, JBR, JBS, JBT, JBU, JBV, JBW, JBX, JBY, JBZ, KBN, KBO, KBP, KBQ, KBR, KBS, KBT, KBU, KBV, KBW, KBX, KBY, KBZ, LBN, LBO, LBP, LBQ, LBR, LBS, LBT, LBU, LBV, LBW, LBX, LBY, LBZ, MBN, MBO, MBP, MBQ, MBR, MBS, MBT, MBU, MBV, MBW, MBX, MBY, MBZ, NBN, NBO, NBP, NBQ, NBR, NBS, NBT, NBU, NBV, NBW, NBX, NBY, NBZ, OBN, OBO, OBP, OBQ, OBR, OBS, OBT, OBU, OBV, OBW, OBX, OBY, OBZ, PBN, PBO, PBP, PBQ, PBR, PBS, PBT, PBU, PBV, PBW, PBX, PBY, PBZ, QBN, QBO, QBP, QBQ, QBR, QBS, QBT, QBU, QBV, QBW, QBX, QBY, QBZ, RBN, RBO, RBP, RBQ, RBR, RBS, RBT, RBU, RBV, RBW, RBX, RBY, RBZ, SBN, SBO, SBP, SBQ, SBR, SBS, SBT, SBU, SBV, SBW, SBX, SBY, SBZ, TBN, TBO, TBP, TBQ, TBR, TBS, TBT, TBU, TBV, TBW, TBX, TBY, TBZ, UBN, UBO, UBP, UBQ, UBR, UBS, UBT, UBU, UBV, UBW, UBX, UBY, UBZ, VBN, VBO, VBP, VBQ, VBR, VBS, VBT, VBU, VBV, VBW, VBX, VBY, VBZ, WBN, WBO, WBP, WBQ, WBR, WBS, WBT, WBU, WBV, WBW, WBX, WBY, WBZ, XBN, XBO, XBP, XBQ, XBR, XBS, XBT, XBU, XBV, XBW, XBX, XBY, XBZ, YBN, YBO, YBP, YBQ, YBR, YBS, YBT, YBU, YBV, YBW, YBX, YBY, YBZ, ZBN, ZBO, ZBP, ZBQ, ZBR, ZBS, ZBT, ZBU, ZBV, ZBW, ZBX, ZBY, ZBZ

Cadence daily

Why it matters FDA clearances for new devices or expanded indications directly enable market entry and broader adoption of noninvasive brain stimulation technologies.

Signal to watch New 510(k) clearances or PMA approvals for TMS, tDCS, or VNS devices, especially for new therapeutic areas, indicate market expansion.

Confidence: high

3. USPTO PatentsView — Patent Grants / Applications

Not in registry

Metric/field Number of new patents granted/applications filed

Cadence weekly

Why it matters Patent activity reflects innovation, competitive positioning, and future product pipelines for companies in the noninvasive brain stimulation space.

Signal to watch Increasing patent grants or applications by theme members or new entrants suggests ongoing R&D and potential for differentiated products.

Confidence: high

4. USASpending.gov — Federal Contract and Grant Awards

Not in registryaccess=api

Metric/field Award amount and recipient for relevant keywords

Cadence daily

Why it matters Federal funding for research or procurement of noninvasive brain stimulation technologies can drive innovation, validate efficacy, and support adoption.

Signal to watch Significant contract or grant awards to theme members or research institutions for noninvasive brain stimulation projects indicate government support and potential for future growth.

Confidence: high

5. Google Trends — Search Interest

Not in registry

Metric/field Search interest index

Cadence daily

Why it matters Public search interest can be a proxy for patient awareness, demand, and general interest in noninvasive brain stimulation treatments and devices.

Signal to watch Rising search interest for key terms or specific company/product names suggests increasing public awareness and potential demand.

Confidence: medium

Paid Alt Data Watch

1. IQVIA / AcuityMD / Definitive Healthcare — Healthcare Claims Data

Matchedacuitymd_medical_claims_procedure_volumes · access=file · map_only

Metric/field Procedure volumes (CPT codes for TMS, tDCS, VNS), diagnosis codes (MDD, OCD, migraine)

Cadence monthly

Why it matters Directly measures the utilization and adoption rates of noninvasive brain stimulation therapies, providing insights into market growth and payer coverage.

Signal to watch Increasing procedure volumes for relevant CPT codes and associated diagnosis codes indicate growing adoption and reimbursement for these therapies.

Confidence: high

2. IDC / GlobalData Healthcare — Medical Device Market Research Reports

Matchedidc_it_spending_market_forecasts · access=file · map_only

Metric/field Market size, growth forecasts, competitive landscape, adoption rates for neurostimulation devices

Cadence quarterly

Why it matters Provides expert analysis and projections on the overall market for noninvasive brain stimulation, including competitive dynamics and future trends.

Signal to watch Upward revisions in market size forecasts or positive shifts in competitive positioning indicate favorable industry trends.

Confidence: high

3. Truveta — EHR Data

Matchedtruveta_outcomes_real_world_evidence · access=file · map_only

Metric/field Patient outcomes, treatment pathways, and real-world evidence for noninvasive brain stimulation therapies

Cadence daily

Why it matters Real-world evidence on patient outcomes and treatment effectiveness can influence clinical guidelines, payer coverage decisions, and physician adoption.

Signal to watch Positive real-world outcomes and improved treatment adherence for noninvasive brain stimulation therapies can accelerate adoption and expand indications.

Confidence: medium

4. Indeed Hiring Lab / Company Careers Pages — Job Postings Data

Matched (medium)iri_retail_pos_scanner_data · access=file · map_only

Metric/field Number of job postings for 'TMS technician', 'neurotech sales', 'clinical specialist - neurostimulation'

Cadence monthly

Why it matters Hiring activity for clinical and sales roles related to noninvasive brain stimulation can indicate expansion plans, increasing demand for services, and market growth.

Signal to watch Consistent increase in relevant job postings by theme members or clinics offering these therapies suggests business expansion and growing market activity.

Confidence: medium

5. AlphaSense — Company Transcripts and Filings Analysis

Matchedalphasense_company_filings_transcripts_research · access=file · map_only

Metric/field Frequency and sentiment of mentions of 'reimbursement', 'payer coverage', 'clinical trials', 'FDA clearance'

Cadence quarterly

Why it matters Analysis of company communications provides direct insights into management's focus areas, challenges, and progress related to market access and regulatory milestones.

Signal to watch Increasing positive mentions or successful outcomes related to reimbursement, payer coverage, and regulatory approvals indicate favorable market conditions and company performance.

Confidence: high

Prediction Market Watch

1. Will Minnesota medical-device manufacturing jobs rise YoY? (2026)

Kalshi · Confidence: medium

Not in registryaccess=api

Market https://kalshi.com/markets/kxmnmeddevemp

Why it matters Minnesota is a significant hub for medical device manufacturing. A rise in medical-device manufacturing jobs could indicate a healthy and growing regulatory or funding environment for the broader medical device sector, which would positively impact the theme constituents involved in developing and manufacturing noninvasive brain stimulation devices. Conversely, a decline could signal headwinds for the industry, affecting stock prices.

Series key kalshi_mn_meddev_jobs_yoy

2. Will Connecticut insurance-industry employment increase YoY in 2026?

Kalshi · Confidence: medium

Not in registryaccess=api

Market https://kalshi.com/markets/kxctinsurancejobs

Why it matters The noninvasive brain stimulation theme is highly dependent on insurance coverage and reimbursement for treatment adoption. An increase in Connecticut's insurance industry employment could signal growth or positive changes within the healthcare insurance sector, potentially leading to expanded coverage or more favorable reimbursement policies for noninvasive brain stimulation therapies, thereby directly impacting the revenue and stock prices of theme constituents.

Series key kalshi_ct_insurance_jobs_yoy

Theme Plain English
Noninvasive brain stimulation captures medical technology companies developing external magnetic and electrical devices that modulate cortical and peripheral neural activity without surgical implants. Anchored by transcranial magnetic stimulation (TMS), transcranial direct current stimulation (tDCS), and noninvasive vagus nerve stimulation (nVNS), these therapies treat medication-resistant major depression, obsessive-compulsive disorder, chronic migraines, and neurological motor deficits. Commercial success hinges on expanding outpatient insurance reimbursement, accelerated multi-session protocols, navigated MRI/EEG brain targeting, and clinic throughput.

News

1 story tagged to this theme — Narrative Radar and editorial picks.

Loading correlation…

Constituents

  • 302550.KQT3
    · no notes yet
  • 380550.KQT3
    · no notes yet
  • 688273.SHGT3
    · no notes yet
  • 688580.SHGT3
    · no notes yet
  • 688626.SHGT3
    · no notes yet
  • BWAYT3
    · no notes yet
  • ECORT3
    · no notes yet
  • NXTMH.HET3
    · no notes yet
  • STIMT3
    · no notes yet